Summary
Morphine, dextromoramide (4 μmol/kg i.p.) and vimonol R2 (17 μmol/kg i.p.) in analgesic doses (28 to 112 μmol/kg i.p.) decreased 3′,5′-cyclic guanosine monophosphate (cGMP) in rat cerebellar cortex; morphine also decreased the cGMP content in deep cerebellar nuclei. Intrastriatal but not intracerebellar injections of morphine (20 μg) decreased cerebellar cGMP content. Naltrexone, an opiate receptor antagonist, but not apomorphine, a dopaminergic receptor agonist, blocked the effect of morphine on cerebellar cGMP. Pretreatment with 3-acetylpyridine (3-AP) which destroys the climbing fibers, failed to antagonize the effect of morphine on cerebellar cGMP. These results suggest that activation of opiate receptors in striatum decreases cerebellar cGMP content presumably by reducing activity in the mossy fiber excitatory input to cerebellum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allen, G. I., Tsukahara, N. T.: Cerebrocerebellar communication systems. Physiol. Rev. 14, 957–1006 (1974)
Biggio, G., Guidotti, A.: Climbing fibers activation and 3,5-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellum. Brain Res. 107, 365–373 (1976)
Biggio, G., Guidotti, A., Costa, E.: GABA activation mediates the decrease of cerebellar cGMP elicited by diazepam. Proc. nat. Acad. Sci. (Wash.) (in press, 1977)
Carenzi, A., Cheney, D. L., Costa, E., Guidotti, A., Racagni, G.: Action of opiates, antipsychotics, amphetamine and apomorphine on dopamine receptors in rat striatum: in vivo changes of 3′,5′-cyclic adenosine monophosphate content and acetylcholine turnover rate. Neuropharmacology 14, 927–939 (1975)
Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drug. Proc. nat. Acad. Sci. (Wash.) 71, 1113–1117 (1974)
Costal, B., Olley, J. E.: Cholinergic and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen. Neuropharmacology 10, 297–306 (1971)
D'Amour, F. E., Smith, D. L.: A method of determining loss of pain sensation. J. Pharmacaol. exp. Ther. 72, 74–79 (1941)
Desclin, J. G., Escubi, J.: Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver methods. Brain Res. 77, 349–364 (1974)
Dill, R., Costa, E.: Behavioral dissociation on the enkaphalinergic systems of nuclei accumbens and caudatus. Neuropharmacology (in press, 1977)
Filburn, C. R., Karn, J.: An isotopic assay of cyclic 3′-5′-nucleotide phosphodiesterase with aluminum oxide columns. Analyt. Biochem. 52, 505–516 (1973)
Fox, M., Williams, I. D.: The caudate nucleus-cerebellar pathways: an electrophysiological study of their route through the midbrain. Brain Res. 20, 140–144 (1970)
Guidotti, A., Cheney, D. L., Trabucchi, M., Doteuchi, M., Wang, C., Hawkins, R. A.: Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology. Neuropharmacology 13, 1115–1122 (1974)
Gullis, R., Traber, J., Hamprecht, B.: Morphine elevates levels of cyclic GMP in a neuroblastoma X glioma hybrid cell line. Nature (Lond.) 256, 57–59 (1975)
Harper, J. F., Brooker, C.: Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0-acetylation by acetic anhydride in aqueous solution. J. Cyclic Nucleotide Res. 1, 207–218 (1975)
Ito, M., Yoshida, M., Obata, K., Kawai, N., Udo, M.: Inhibitory control of intracerebellar nuclei by Purkinje cell axons. Exp. Brain Res. 10, 64–80 (1970)
Kemp, J. M., Powell, T. P. S.: The connections of the striatum and globus pallidus: synthesis and speculations. Phil. Trans. B 13, 262, 441–457 (1971)
Koslow, S. H., Schlumpf, M.: Quantitation of adrenaline in rat brain nuclei and areas by mass fragmentography. Nature (Lond.) 251, 530–531 (1974)
Litchfield, J. T., Wilcoxon, F.: A simplified method of evaluating dose effect experiments. J. Pharmacol. exp. Ther. 96, 99–113 (1949)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
Mao, C. C., Guidotti, A.: Simultaneous isolation of adenosine 3′,5′ cyclic monophosphate (cAMP) and guanosine 3,5 cyclic monophosphate (cGMP) in small tissue samples. Analyt. Biochem. 59, 63–68 (1974)
Mao, C. C., Guidotti, A., Landis, S.: Cyclic GMP: reduction of cerebellar concentration in nervous mutant mice. Brain Res. 90, 335–339 (1975)
Minneman, K. P., Iversen, L. L.: Enkephalin and opiate narcotics increase cGMP accumulation in slices of rat neostriatum. Nature (Lond.) 262, 313–314 (1976)
Pellegrino, L., Dushman, A. J.: A stereotaxic atlas of the rat brain. New York: Appleton Century Crafts 1967
Pert, C. B., Snyder, S. H.: Opiate receptor: demonstration in nervous system tissue. Science 179, 1011–1014 (1973)
Racagni, G., Zsilla, G., Guidotti, A., Costa, E.: Accumulation of cGMP in striatum of rats injected with narcotic analgesics: antagonism by naltrexone. J. Pharm. Pharmacol. 28, 258–260 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Biggio, G., Guidotti, A. & Costa, E. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 296, 117–121 (1977). https://doi.org/10.1007/BF00508462
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00508462